Reprints
PubMed
CAVEAT LECTOR
The DCC Protein -- NEURAL DEVELOPMENT AND THE MALIGNANT PROCESS
Kimberly M. Rieger-Christ, Karina L. Brierley and Michael A. Reale
Department of Internal Medicine/Oncology, Yale School of Medicine/West Haven Veterans Administration Medical Center, 333 Cedar St., P.O. Box 208032, New Haven, CT 06520-8032
Received 8/25/97 Accepted 9/5/97
TABLE OF CONTENTS
7. REFERENCES
1. Vogelstein, B., E. R. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger, M. Lepper, Y. Nakamura, R. White, A. M. M. Smits, & J. L. Bos: Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319, 525-532 (1988)
2. Ookawa, K., M. Sakamoto, S. Hirohashi, Y. Yoshida, T. Sugimura, M. Terada, & J. Yokota: Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. International J Cancer 53, 382-387 (1993)
3. Cho, K. R., J. D. Oliner, J. W. Simons, L. Hedrick, E. R. Fearon, A. C. Preisinger, P. Hedge, G. A. Silverman, & B. Vogelstein: The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19, 525-531 (1994)
4. Fearon, E. R., K. R. Cho, J. M. Nigro, S. E. Kern, J. W. Simons, J. M. Ruppert, S. R. Hamilton, A. C. Preisinger, G. Thomas, K. W. Kinzler, & B. Vogelstein: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49-56 (1990)
5. Hedrick, L., K. R. Cho, E. R. Fearon, J. D. Oliner, K. W. Kinzler, & B. Vogelstein: The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8, 1174-1183 (1994)
6. Reale, M. A., G. Hu, R. H. Getzenberg, A. I. Zafar, S. M. Levine, & E. R. Fearon: Expression of the deleted in colorectal cancer (DCC) tumor suppressor gene in cell lines and normal and malignant tissues -- evidence for alternative splicing. Cancer Res 54, 4493-4501 (1994)
7. Vielmetter, J., J. F. Kayyem, J. M. Roman, & W. J. Dreyer: Neogenin, an avian cell surface protein expressed during terminal neuronal differentiation, is closely related to the human tumor suppressor molecule deleted in colorectal cancer. J Cell Biol 127, 2009-20 (1994)
8. Chan, S. S., H. Zheng, M. W. Su, R. Wilk, M. T. Killeen, E. M. Hedgecock, & J. G. Culotti: UNC-40, a C. elegans homolog of DCC (Deleted in Colorectal Cancer), is required in motile cells responding to UNC-6 netrin cues. Cell 87, 187-95 (1996)
9. Keino-Masu, K., M. Masu, L. Hinck, E. D. Leonardo, S.-Y. Chan, J. G. Culotti, & M. Tessier-Lavigne: Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 87, 175-185 (1996)
10. Kolodziej, P. A., L. C. Timpe, K. J. Mitchell, S. R. Fried, C. S. Goodman, L. Y. Jan, & Y. N. Jan: frazzled encodes a Drosophila member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance. Cell 87, 197-204 (1996)
11. Cooper, H. M., P. Armes, J. Britto, J. Gad, & A. F. Wilks: Cloning of the mouse homologue of the deleted in colorectal cancer gene (mDCC) and its expression in the developing mouse embryo. Oncogene 11, 2243-54 (1995)
12. Pierceall, W. E., M. A. Reale, A. F. Candia, C. V. E. Wright, K. R. Cho, & E. R. Fearon: Expression of a Xenopus laevis homologue of the deleted in colorectal cancer (DCC) tumor suppressor gene is developmentally regulated. Devel. Biol. 166, 654-665 (1994)
13. Ekstrand, B. C., T. Mansfield, S. Bigner, & E. R. Fearon: DCC expression is altered by multiple mechanisms in human brain tumors. Oncogene 11, 2393-2402 (1995)
14. Chuong, C.-M., T.-X. Jiang, E. Yin, & R. B. Widelitz: cDCC (chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction. Develop Biol 164, 383-397 (1994)
15. Lawlor, K. G., & R. Narayanan: Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth & Differ 3, 609-616 (1992)
16. Pierceall, W. E., K. R. Cho, R. H. Getzenberg, M. A. Reale, L. Hedrick, B. Vogelstein, & E. R. Fearon: The deleted in colorectal cancer (DCC) tumor suppressor gene product stimulates neurite outgrowth in rat PC12 pheochromocytoma cells. J Cell Biol 124, 1017-1027 (1994)
17. Tanaka, E., & J. Sabry: Making the connection: cytoskeletal rearrangements during growth cone guidance. Cell 83, 171-6 (1995)
18. Keynes, R., & G. M. Cook: Axon guidance molecules. Cell 83, 161-9 (1995)
19. Tessier-Lavigne, M., M. Placzek, A. G. Lumsden, J. Dodd, & T. M. Jessell: Chemotropic guidance of developing axons in the mammalian central nervous system. Nature 336, 775-8 (1988)
20. Serafini, T., T. E. Kennedy, M. J. Galko, C. Mirzayan, T. M. Jessell, & M. Tessier-Lavigne: The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78, 409-24 (1994)
21. Harris, R., L. M. Sabatelli, & M. A. Seeger: Guidance cues at the Drosophila CNS midline: identification and characterization of two Drosophila Netrin/UNC-6 homologs. Neuron 17, 217-28 (1996)
22. Hedgecock, E. M., J. G. Culotti, & D. H. Hall: The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron 4, 61-85 (1990)
23. Ishii, N., W. G. Wadsworth, B. D. Stern, J. G. Culotti, & E. M. Hedgecock: UNC-6, a laminin-related protein, guides cell and pioneer axon migrations in C. elegans. Neuron 9, 873-81 (1992)
24. Leonardo, E. D., L. Hinck, M. Masu, K. Keino-Masu, S. L. Ackerman, & M. Tessier-Lavigne: Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386, 833-8 (1997)
25. Ackerman, S. L., L. P. Kozak, S. A. Przyborski, L. A. Rund, B. B. Boyer, & B. B. Knowles: The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature 386, 838-42 (1997)
26. Drescher, U.: Netrins find their receptor [news]. Nature 384, 416-7 (1996)
27. Goodman, C. S.: The likeness of being: phylogenetically conserved molecular mechanisms of growth cone guidance. Cell 78, 353-6 (1994)
28. Serafini, T., S. A. Colamarino, E. D. Leonardo, H. Wang, R. Beddington, W. C. Skarnes, & M. Tessier-Lavigne: Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 87, 1001-14 (1996)
29. Fazeli, A., S. L. Dickinson, M. Hermiston, R. V. Tighe, R. G. Steen, C. G. Small, K. Keinu-Masu, M. Masu, H. Rayburn, J. Simons, R. T. Bronson, J. I. Gordon, M. Tessier-Lavigne, & R. A. Weinberg: Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc). Nature 386, 796 (1997)
30. Peifer, M.: Cell adhesion and signal transduction: the armadillo connection. Trends Cell Biol 5, 224-229 (1995)
31. Morin, P. J., A. B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, & K. W. Kinzler: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790 (1997)
32. Rubinfeld, B., P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, & P. Polakis: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792 (1997)
33. Bourrat, F., & C. Sotelo: Migratory pathways and selective aggregation of the lateral reticular neurons in the rat embryo: a horseradish peroxidase in vitro study, with special reference to migration patterns of the precerebellar nuclei. J Comp Neurol 294, 1-13 (1990)
34. Miyamoto, H., T. Shuin, I. Ikeda, M. Hosaka, & Y. Kubota: Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. J Urol 155, 1444-7 (1996)
35. Brewster, S. F., J. C. Gingell, S. Browne, & K. W. Brown: Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer 70, 697-700 (1994)
36. Dalbagni, G., J. Presti, V. Reuter, W. R. Fair, & C. Cordon-Cardo: Genetic alterations in bladder cancer [see comments]. Lancet 342, 469-71 (1993)
37. Presti, J. C., Jr., V. E. Reuter, T. Galan, W. R. Fair, & C. Cordon-Cardo: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51, 5405-9 (1991)
38. Huang, T. H., P. L. Yeh, M. B. Martin, R. E. Straub, T. C. Gilliam, C. W. Caldwell, & J. L. Skibba: Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. Diagn Mol Pathol 4, 66-72 (1995)
39. Thompson, A. M., R. G. Morris, M. Wallace, A. H. Wyllie, C. M. Steel, & D. C. Carter: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68, 64-8 (1993)
40. Devilee, P., M. van Vliet, N. Kuipers-Dijkshoorn, P. L. Pearson, & C. J. Cornelisse: Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene 6, 311-5 (1991)
41. Cropp, C. S., R. Lidereau, G. Campbell, M. H. Champene, & R. Callahan: Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci U S A 87, 7737-41 (1990)
42. Shibata, D., M. A. Reale, P. Lavin, M. Silverman, E. R. Fearon, G. Steele Jr., M. J. Jessup, M. Loda, & I. C. Summerhayes: Loss of DCC expression and prognosis in colorectal cancer. N Engl J Med 335, 1727-1732 (1996)
43. Jen, J., H. Kim, S. Piantadosi, Z. F. Liu, R. C. Levitt, P. Sistonen, K. W. Kinzler, B. Vogelstein, & S. R. Hamilton: Allelic loss of chromosome 18q and prognosis in colorectal cancer [see comments]. N Engl J Med 331, 213-21 (1994)
44. Iino, H., M. Fukayama, Y. Maeda, M. Koike, T. Mori, T. Takahashi, R. Kikuchi-Yanoshita, M. Miyaki, S. Mizuno, & S. Watanabe: Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 73, 1324-31 (1994)
45. Itoh, F., Y. Hinoda, M. Ohe, Y. Ohe, T. Ban, T. Endo, K. Imai, & A. Yachi: Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 53, 260-3 (1993)
46. Kikuchi-Yanoshita, R., M. Konishi, H. Fukunari, K. Tanaka, & M. Miyaki: Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52, 3801-3 (1992)
47. Enomoto, T., M. Fujita, C. Cheng, R. Nakashima, M. Ozaki, M. Inoue, & T. Nomura: Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 71, 462-7 (1995)
48. Gima, T., H. Kato, T. Honda, T. Imamura, T. Sasazuki, & N. Wake: DCC gene alteration in human endometrial carcinomas. Int J Cancer 57, 480-5 (1994)
49. Fujino, T., J. I. Risinger, N. K. Collins, F. S. Liu, H. Nishii, H. Takahashi, E. M. Westphal, J. C. Barrett, H. Sasaki, and M. F. Kohler: Allelotype of endometrial carcinoma. Cancer Res 54, 4294-8 (1994)
50. Imamura, T., T. Arima, H. Kato, S. Miyamoto, T. Sasazuki, & N. Wake: Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 51, 47-52 (1992)
51. Maesawa, C., G. Tamura, S. Ogasawara, Y. Suzuki, K. Sakata, J. Sugimura, S. Nishizuka, N. Sato, K. Ishida, K. Saito, & R. Satodate: Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma. Eur J Cancer 32A, 896-8 (1996)
52. Miyake, S., K. Nagai, K. Yoshino, M. Oto, M. Endo, & Y. Yuasa: Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54, 3007-10 (1994)
53. Shibagaki, I., Y. Shimada, T. Wagata, M. Ikenaga, M. Imamura, & K. Ishizaki: Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 54, 2996-3000 (1994)
54. Huang, Y., R. F. Boynton, P. L. Blount, R. J. Silverstein, J. Yin, Y. Tong, T. K. McDaniel, C. Newkirk, J. H. Resau, & R. Sridhara: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52, 6525-30 (1992)
55. Cho, J. H., M. Noguchi, A. Ochiai, & S. Hirohashi: Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest 74, 835-41 (1996)
56. Schneider, B. G., D. R. Pulitzer, R. D. Brown, T. J. Prihoda, D. G. Bostwick, V. Saldivar, H. A. Rodriguez-Martinez, M. E. Gutierrez-Diaz, & P. O'Connell: Allelic imbalance in gastric cancer: an affected site on chromosome arm 3p. Genes Chromosomes Cancer 13, 263-71 (1995)
57. Uchino, S., H. Tsuda, M. Noguchi, J. Yokota, M. Terada, T. Saito, M. Kobayashi, T. Sugimura, & S. Hirohashi: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52, 3099-102 (1992)
58. Peng, H. Q., D. Bailey, D. Bronson, P. E. Goss, & D. Hogg: Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 55, 2871-5 (1995)
59. Murty, V. V., G. J. Bosl, J. Houldsworth, M. Meyers, A. B. Mukherjee, V. Reuter, & R. S. Chaganti: Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene 9, 2245-51 (1994)
60. Reyes-Mugica, M., K. Rieger-Christ, H. Hogaki, M. Helie, G. Kleinman, B. C. Ekstrand, P. Kleihues, E. R. Fearon, & M. A. Reale: Loss of DCC expression and glioma progression. Cancer Res 57, 382-386 (1997)
61. Scheck, A. C., & S. W. Coons: Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 53, 5605-5609 (1993)
62. Miyake, K., K. Inokuchi, K. Dan, & T. Nomura: Expression of the DCC gene in myelodysplastic syndromes and overt leukemia. Leuk Res 17, 785-8 (1993)
63. Porfiri, E., L. M. Secker-Walker, A. V. Hoffbrand, & J. F. Hancock: DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood 81, 2696-701 (1993)
64. Miyake, K., K. Inokuchi, K. Dan, & T. Nomura: Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 82, 927-30 (1993)
65. Reale, M. A., M. Reyes-Mugica, W. E. Pierceall, M. C. Rubinstein, L. Hedrick, S. L. Cohn, A. Nakagawara, G. M. Brodeur, & E. R. Fearon: Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin Cancer Res 2, 1097-1102 (1996)
66. Takita, J., Y. Hayashi, T. Kohno, M. Shiseki, N. Yamaguchi, R. Hanada, K. Yamamoto, & J. Yokota: Allelotype of neuroblastoma. Oncogene 11, 1829-1834 (1995)
67. Yamaguchi, T., J. Toguchida, T. Yamamuro, Y. Kotoura, N. Takada, N. Kawaguchi, Y. Kaneko, Y. Nakamura, M. S. Sasaki, & K. Ishizaki: Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52, 2419-23 (1992)
68. Toguchida, J., K. Ishizaki, M. S. Sasaki, M. Ikenaga, M. Sugimoto, Y. Kotoura, & T. Yamamuro: Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48, 3939-43 (1988)
69. Chenevix-Trench, G., J. Leary, J. Kerr, J. Michel, R. Kefford, T. Hurst, P. G. Parsons, M. Friedlander, & S. K. Khoo: Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7, 1059-65 (1992)
70. Hahn, S. A., M. Schutte, A. T. M. Shamsul Hoque, C. A. Moskaluk, L. T. da Costa, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, R. H. Hruban, & S. E. Kern: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996)
71. Seymour, A. B., R. H. Hruban, M. Redston, C. Caldas, S. M. Powell, K. W. Kinzler, C. J. Yeo, & S. E. Kern: Allelotype of pancreatic adenocarcinoma. Cancer Res 54, 2761-4 (1994)
72. Simon, B., R. Weinel, M. Hohne, J. Watz, J. Schmidt, G. Kortner, & R. Arnold: Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology 106, 1645-51 (1994)
73. Hohne, M. W., M. E. Halatsch, G. F. Kahl, & R. J. Weinel: Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 52, 2616-9 (1992)
74. Crundwell, M. C., S. Chughtai, M. Knowles, L. Takle, M. Luscombe, J. P. Neoptolemos, D. G. Morton, & S. M. Phillips: Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer. Int J Cancer 69, 295-300 (1996)
75. Latil, A., J. C. Baron, O. Cussenot, G. Fournier, T. Soussi, L. Boccon-Gibod, A. Le Duc, J. Rouesse, & R. Lidereau: Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes Cancer 11, 119-25 (1994)
76. Brewster, S. F., S. Browne, & K. W. Brown: Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151, 1073-7 (1994)
77. Gao, X., K. V. Honn, D. Grignon, W. Sakr, & Y. Q. Chen: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53, 2723-7 (1993)
78. Carter, B. S., C. M. Ewing, W. S. Ward, B. F. Treiger, T. W. Aalders, J. A. Schalken, J. I. Epstein, & W. B. Isaacs: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci U S A 87, 8751-5 (1990)
79. Campuzano, V., L. Montermini, M. D. Molto, L. Pianese, M. Cossee, F. Cavalcanti, E. Monros, F. Rodius, F. Duclos, A. Monticelli, F. Zara, J. Canizares, H. Koutnikova, S. I. Bidichandani, C. Gellera, A. Brice, P. Trouillas, G. De Michele, A. Filla, R. De Frutos, F. Palau, P. I. Pragna, S. Di Donato, J-L. Mandel, S. Cocozza, M. Koenig and M. Pandolfo.: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion [see comments]. Science 271, 1423-7 (1996)
80. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, & D. Sidransky: 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1, 686-692 (1995)
81. Herman, J. G., F. Latif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D. S. Duan, J. R. Gnarra, & W. M. Linehan: Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91, 9700-9704 (1994)
82. Eppert, K., S. W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.-C. Tsue, B. Bapat, S. Gallinger, I. L. Andrulis, G. H. Thomsen, J. L. Wrana, & L. Attisano: MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996)
83. Takagi, Y., H. Kohmura, M. Futamura, H. Kida, H. Tanemura, K. Shimokawa, & S. Saji: Somatic alterations of the DPC4 gene in human colorectal cancers in vivo [see comments]. Gastroenterology 111, 1369-72 (1996)
84. Thiagalingam, S., C. Lengauer, F. S. Leach, M. Schutte, S. A. Hahn, J. Overhauser, J. K. V. Willson, S. Markowitz, S. R. Hamilton, S. E. Kern, K. W. Kinzler, and B. Vogelstein: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genetics 13, 343-346 (1996)
85. Barrett, M. T., M. Schutte, S. E. Kern, & B. J. Reid: Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 56, 4351-3 (1996)
86. Kim, S. K., Y. Fan, V. Papadimitrakopoulou, G. Clayman, W. N. Hittelman, W. K. Hong, R. Lotan, & L. Mao: DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 56, 2519-21 (1996)
87. Lei, J., T. T. Zou, Y. Q. Shi, X. Zhou, K. N. Smolinski, J. Yin, R. F. Souza, R. Appel, S. Wang, K. Cymes, O. Chan, J. M. Abraham, N. Harpaz, & S. J. Meltzer: Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 13, 2459-62 (1996)
88. Schutte, M., R. H. Hruban, L. Hedrick, K. R. Cho, G. M. Nadasdy, C. L. Weinstein, G. S. Bova, W. B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, R. A. Casero, Jr., P. S. Meltzer, S. A. Hahn, & S. E. Kern: DPC4 gene in various tumor types. Cancer Res 56, 2527-30 (1996)
89. Riggins, G. J., S. Thiagalingam, E. Rozenblum, C. L. Weinstein, S. E. Kern, S. R. Hamilton, J. K. Willson, S. D. Markowitz, K. W. Kinzler, & B. Vogelstein: Mad-related genes in the human. Nat Genet 13, 347-9 (1996)
90. Banerjee, A. K.: DCC expression and prognosis in colorectal cancer. Lancet 349, 968 (1997)
91. Louis, D. N., & J. F. Gusella: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genetics 11, 412-415 (1995)
92. Kleihues, P., F. Soylemezoglu, B. Schauble, B. W. Scheithauer, & P. C. Burger: Histopathology, classification, and grading of gliomas. Glia 15, 211-221 (1995)
93. Cavenee, W. K.: Accumulation of genetic defects during astrocytoma progression. Cancer (Suppl) 70, 1788-1793 (1992)
93. Narayanan, R., R. Q. J. Schaapveld, K. R. Cho, B. Vogelstein, P. B. V. Tran, M. P. Osborne, & N. T. Telang: Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 7, 553-561 (1992)
94. Klingelhutz, A. J., L. Hedrick, K. R. Cho, & J. K. McDougal: The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10, 1581-1586 (1995)
95. Hahn, H., C. Wicking, P. G. Zaphiropoulous, M. R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. B. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D. J. Leffell, B. Gerrard, A. M. Goldstein, M. Dean, R. Toftgard, G. Chenevix-Trench, B. Wainwright, & A. E. Bale: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-51 (1996)